94 related articles for article (PubMed ID: 6833441)
1. Analysis of adriamycin and adriamycinol in micro volumes of rat plasma.
Bots AM; Van Oort WJ; Noordhoek J; Van Dijk A; Klein SW; Van Hoesel QG
J Chromatogr; 1983 Feb; 272(2):421-7. PubMed ID: 6833441
[No Abstract] [Full Text] [Related]
2. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography.
Cummings J; Stuart JF; Calman KC
J Chromatogr; 1984 Nov; 311(1):125-33. PubMed ID: 6520153
[TBL] [Abstract][Full Text] [Related]
3. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
[TBL] [Abstract][Full Text] [Related]
4. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
Pierce RN; Jatlow PI
J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422
[TBL] [Abstract][Full Text] [Related]
5. Time dependency of adriamycin and adriamycinol kinetics.
Gil P; Favre R; Durand A; Iliadis A; Cano JP; Carcassonne Y
Cancer Chemother Pharmacol; 1983; 10(2):120-4. PubMed ID: 6831625
[TBL] [Abstract][Full Text] [Related]
6. New data on the pharmacokinetics of adriamycin and its major metabolite, adriamycinol.
Leca F; Marchiset-Leca D; Noble A; Antonetti M
Eur J Drug Metab Pharmacokinet; 1991; 16(2):107-11. PubMed ID: 1936069
[TBL] [Abstract][Full Text] [Related]
7. Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol.
Eksborg S; Ehrsson H; Andersson I
J Chromatogr; 1979 Dec; 164(4):479-86. PubMed ID: 541423
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxic effects of adriamycin and mitochondrial oxidation in rat cardiac tissue.
Montali U; Del Tacca M; Bernardini C; Segnini D; Solaini G
Drugs Exp Clin Res; 1985; 11(3):219-22. PubMed ID: 3836126
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hours.
Lee HJ; Lee MG
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):299-306. PubMed ID: 9261889
[TBL] [Abstract][Full Text] [Related]
10. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
[TBL] [Abstract][Full Text] [Related]
11. [Possible role of adriamycinol in the cardiotoxicity induced by adriamycin in the rat].
Danesi R; Del Tacca M; Ducci M; Bernardini C; Romanini A
G Ital Chemioter; 1985; 32(1):31-3. PubMed ID: 3830790
[No Abstract] [Full Text] [Related]
12. Mathematical model for adriamycin (doxorubicin) pharmacokinetics.
Reich SD; Steinberg F; Bachur NR; Riggs CE; Goebel R; Berman M
Cancer Chemother Pharmacol; 1979; 3(2):125-31. PubMed ID: 509697
[TBL] [Abstract][Full Text] [Related]
13. General and cardiac toxicity of adriamycinol in rats.
Danesi R; Del Tacca M; Della Torre P; Bernardini C
Anticancer Res; 1986; 6(5):967-72. PubMed ID: 3800337
[TBL] [Abstract][Full Text] [Related]
14. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.
Erb N; Erttmann R; Landbeck G
Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of adriamycin in rat hepatocytes using a volatile extraction buffer, HPLC and fluorescence detection.
Mahdadi R; Pommery N; Pommery J; Lhermitte M
Biomed Chromatogr; 1987; 2(3):91-4. PubMed ID: 3507221
[TBL] [Abstract][Full Text] [Related]
16. Determination of adriamycin and its fluorescent metabolites in human plasma by HPLC.
Mahdadi R; Lhermitte M; Lafitte JJ
Biomed Chromatogr; 1987 Feb; 2(1):38-40. PubMed ID: 3508093
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat.
Hartman N; Basseches PJ; Powis G
Cancer Chemother Pharmacol; 1982 Dec; 10(1):11-5. PubMed ID: 6819097
[TBL] [Abstract][Full Text] [Related]
18. Superoxide anion production by adriamycinol from cardiac sarcosomes and by mitochondrial NADH dehydrogenase.
Gervasi PG; Agrillo MR; Citti L; Danesi R; Del Tacca M
Anticancer Res; 1986; 6(5):1231-5. PubMed ID: 3026233
[TBL] [Abstract][Full Text] [Related]
19. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].
Ehninger G; Stocker HJ; Proksch B; Wilms K
Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.
Gewirtz DA; Yanovich S
Biochem Pharmacol; 1987 Jun; 36(11):1793-8. PubMed ID: 3579974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
